Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing – Genetically modified micro-organism – cell – or virus
Patent
1997-07-30
1999-11-16
Crouch, Deborah
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
Genetically modified micro-organism, cell, or virus
424 932, 514 44, 435325, 4353201, A61K 4800, C12N 1500
Patent
active
059852666
ABSTRACT:
The present invention pertains to combination radio therapy of tumors and more specifically to pharmaceutical compositions, and methods of treatment by gene therapy designed to sensitize tumors in animals, notably humans, and render them more susceptible to radiation, thus significantly reducing the amount of radiation required to kill neoplastic cells while at the same time making the radiation far more tissue specific to the tumor site.
REFERENCES:
patent: 4894364 (1990-01-01), Greer
patent: 5529774 (1996-06-01), Barba et al.
patent: 5631236 (1997-05-01), Woo
Muller (1994) Pharmac. Ther. 63, 199-207.
Bi, 1993, In Vitro Evidence that Metabolic Cooperation is Responsible for the Bystander Effect Observed with HSV tk Retroviral Gene Therapy, Human Gene Therapy 4:725-731.
Borrelli, "Targeting of an Inducible Toxic Phenotype in Animal Cells", Proc. Natl. Acad. Sci. USA, vol. 85:7572-7576 (1988).
Caruso, 1993, Regression of Established Macroscopic Liver Metastases After In Situ Transduction of a Suicide Gene, Proc. Natl. Acad. Sci. USA, vol. 90:7024-7028.
Chen, 1994, Gene Therapy for Brain Tumors: Regression of Experimental Gliomas by Adenovirus-Mediated Gene Transfer In Vivo, Proc. Natl. Acad. Sci, USA, 91:3054-3057.
Cheng, "Metabolism of 9-(1,3-Dihydroxy-2-Propoxymethyl)guanine, a New Anti-herpes Virus Compound, in Herpes Simplex Virus-Infected Cells", The Journal of Biological Chemistry, vol. 258(20):12460-12464 (1983).
Culver, "In Vivo Gene Transfer with Retroviral Vector-Producer Cells for Treatment of Experimental Brain Tumors", Science, vol. 256:1550-1552 (1992).
Culver, "Gene Therapy for Cancer", Trends in Genetics, vol. 10(5) May 1994.
Elion, "The Chemotherapeutic Exploitation of Virus-Specified Enzymes", Adv. Enz. Regulation, 18:53-66 (1980).
Freeman, "The `Bystander Effect`: Tumor Regression When a Fraction of the Tumor Mass is Genetically Modified", Cancer Research, 53:5274-5283 (1993).
Goffman, T., "Long-Term Follow-Up on National Cancer Institute Phase I/II Study of Glioblastoma Multiforme Treated With Iododeoxyuridine and Hyperfractionated Irradiation", J. of Clinical Oncology, 10(2):264-268 (1992).
Greer, "5-Halogenated Analogs of Deoxycytidine as Selective Inhibitors of the Replication of Herpes Simplex Viruses in Cell Culture and Related Studies of Intracranial Herpes Simplex Virus Infections in Mice", Annals New York Academy of Sciences, vol. 255:359-365 (1975).
Harrison, D., "Competitive Repopulation in Unirradiated Normal Recipients", Blood, J. of The American Society of Hematology, 81(10):2473-2474 (1993).
Heyman, "Thymidine Kinase Obliteration: Creation of Transgenic Mice with Controlled Immune Deficiency", Proc. Natl. Acad. Sci. USA, vol. 86:2698-2702 (1989).
Hodgson, C., "Advances in Vector Systems for Gene Therapy", Patent Update Biologicals & Immunologicals, Exp. Opin. Ther. Patents 5(5):459-468 (1995).
Huber, "Retroviral-Mediated Gene Therapy for the Treatment of Hepatocellular carcinola: An Innovative Approach for Cancer Therapy", Proc. Natl. Acad. Sci. USA, vol. 88:8039-8043 (1991).
Kim, "Selective Enhancement by an Antiviral Agent of the Radiation-Induced Cell Killing of Human Glioma Cells Transduced with HSV-tk Gene", Cancer Research vol. 54:6053-6056 (1994).
Kim, J., "Use of Retroviral Gene Transfer and Antiviral Agents as Radiation Sensitizers in Cultured Brain Tumor Cells", abstract, Proceedings of American Assoc. for Cancer Research, 35:637 (1994).
Marshall, E., "Gene Therapy's Growing Pains", Science, 269:1050-1055 (1995).
Miller, N., "Targeted Vectors for Gene Therapy", FASEB Journal, 9:190-199 (1995).
Mitchell, J., "Radiobiology and Clinical Application of Halogenated Pyrimidine Radiosensitizers", Int. J. Radiat. Biol., 56(5):827-836 (1989).
Moolten, "Tumor Chenosensitivity Conferred by Inserted Herpes Thymidine Kinase Genes: Paradigm for a Prospective Cancer Control Stratety", Cancer Research, 46:5276-5281 (1986).
Moolten, "Curability of Tumors Bearing Herpes Thymidine Kinase Genes Transferred by Retroviral Vectors", Reports, vol. 82(4):297-300 (1990).
Moolten, "Lymphoma Regression Induced by Ganciclovir in Mice Bearing a Herpes Thymidine Kinase Transgene", Human Gene Therapy, 1:125-134 (1990).
Ohno, Gene Therapy for Vascular Smooth Muscle Cells Proliferation After Arterial Injury, Science, vol. 265:781-784 (1994).
Orkin, Report and Recommendations of the Panel to Assess the NIH Investment in Research on Gene Therapy (1995).
Plautz, "Selective Elimination of Recombinant Genes In Vivo with a Suicide Retroviral Vector", The New Biologist, vol. 3(7):709-715 (1991).
Ram, 1993, In Situ Retroviral-Mediated Gene Transfer for the Treatment of Brain Tumors in Rats, Cancer Research, 53:83-88.
Ram, 1993, Toxicity Studies of Retroviral-Mediated Gene Transfer for the Treatment of Brain Tumors, J. Neurosurg., vol. 79:400-407.
Ram, "In Vivo Transfer of the Human Interleukin-2 Gene: Negative Tumoricidal Results in Experimental Brain Tumors", J. Neurosurg. 80:535-540 (1994).
Ram, "Gene Therapy for Malignant Brain Tumors: Preliminary Results of a Clinical Study", Surgical Neurology Branch, NINDS, NIH, Bethesda, MD.
Takamiya, "An Experimental Model of Retrovirus Gene Therapy for Malignant Brain Tumors", J. Neurosurg. 79:104-110, 1993.
Vile, "Use of Tissue-Specific Expression of the Herpes Simplex Virus Thymidine Kinase Gene to Inhibit Growth of Established Murine Melanomas Following Direct Intratumoral Injection of DNA", Cancer Research 53:3860-3864 (1993).
Weichselbaum, "Gene Therapy Targeted by Ionizing Radiation", International Journal of Radiation Oncology Biology Physics, vol 24:565-567 (1992).
Greer Sheldon B.
Link, Jr. Charles J.
Crouch Deborah
Human Gene Therapy Research Institute
LandOfFree
Radiation enhanced therapy for tumors expressing a gene for vira does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Radiation enhanced therapy for tumors expressing a gene for vira, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Radiation enhanced therapy for tumors expressing a gene for vira will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1320615